4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-015839
Options or other derivatives
- Chief Financial Officer acquired 150,185 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reed Joshua Chief Financial Officer | 2021-04-12 | Grant or award · Employee Stock Option (Right to Buy) | +150,185 | 150,185 | D | ||
Loading xslF345X03/doc4.xml…